Navigation Links
Therapure Biopharma Inc. announces collaboration with BioVectra Inc.
Date:11/4/2008

Canadian companies team up in specialty biologics development

TORONTO and CHARLOTTETOWN, Nov. 4 /PRNewswire/ - BioVectra Inc. and Therapure BioPharma Inc. have agreed to partner in the development of a PEGylated biologic drug target used for cancer treatments, with a goal of advancing the project to a regulatory filing stage, suitable for a marketing partner to add to its portfolio of biologic products.

Over the past five years, BioVectra has been developing proprietary technologies for PEGylation as a mechanism for drug delivery. The partnership with Therapure builds upon BioVectra's expertise in the production of modified biologic molecules using a proprietary MPEG technology.

Therapure, from its 130,000 sq. ft facilities in Mississauga, Ontario, adds proprietary purification techniques and impressive formulation, fill, and finish expertise in biologics handling.

"We are very excited about working with BioVectra," said Thomas Wellner, President and CEO of Therapure Biopharma. "They bring significant expertise in active pharmaceutical ingredient development and a high degree of competence and commitment to our partnership."

"Our current program for drug development depends on finding the right partners," said Dale Zajicek, COO and VP of Business Development for BioVectra. "We know we have made a good choice in Therapure Biopharma and we look forward to working together to further the development and commercialization of this product."

About Therapure Biopharma:

Therapure Biopharma Inc. is an integrated biopharmaceutical company that develops, manufactures, purifies, and packages therapeutic proteins. Therapure Biopharma acquired its Canadian-built and conceived facility from Hemosol Corporation, a specialist in therapies derived from hemoglobin, a blood protein. Therapure Biopharma applies scientific, manufacturing, and downstream purification expertise with an intimate understanding of advanced biology, compl
'/>"/>

SOURCE Therapure Biopharma Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Therapure Biopharma Inc. announces collaboration with Induce Biologics Inc.
2. Therapure Biopharma Inc. opens for business with first client contracts
3. Morria Biopharmaceuticals Plc to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
4. Helix BioPharma Corp. Announces Fiscal 2008 Results
5. Keryx Biopharmaceuticals Notified that Nasdaq Has Extended Minimum Bid Price Rule Compliance Period
6. CeNeRx BioPharma Completes $15 Million Series B Financing
7. Lilly Recognized as One of the Worlds Top Biopharmaceutical Employers
8. Millennium Ranks in the Top 10 Best Biopharma Employers in the World by Science Magazine
9. Morria Biopharmaceuticals Plc Announces Results From its Pre-Clinical Screening of Novel Anti-Inflammatory Compounds
10. Helix Biopharma Closes $11.4 Million Private Placement
11. ARCA biopharma to Present at JMP Securities Healthcare Focus Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science ... ), spoke at a conference on High-Risk ... 2009. Beike is China,s leading,stem cell research and ... The conference, organized by the Indian Podiatry Association ...
(Date:12/2/2009)... Dec. 2 Reportlinker.com announces that a ... its catalogue: ,, Drug Discovery Technologies ... & Opportunities ,, http://www.reportlinker.com/p0164246/Drug-Discovery-Technologies---A-Global-Update-of-Market-Trends--Opportunities.html ... and ongoing element of every pharmaceutical company,s ...
(Date:12/2/2009)... , - "Bolstering ... Coinciding with the International ... is hosting an international conference in Libreville,(Gabon) on ... The,conference will be attended by government and state ...
(Date:12/2/2009)... Va., Dec. 2 /PRNewswire-Asia-FirstCall/ -- Emerald Dairy, Inc.,("Emerald Dairy" ... and distributor of infant and children,s formula, milk powder ... will be featured,in the Spring issue of US Food ... over 250,000 executives in the food and beverage industry. ...
Breaking Biology Technology:Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Libreville International Conference 2-3 June 2010 2Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2
... University of Wisconsin-Madison has dropped a PeopleSoft database ... Wisconsin Alumni Association has used for 12 years. , ... database, a custom software system based on a database from ... WAA, is a non-profit organization separate from the university. When ...
... University of Wisconsin-Madison professor of computer science, a department member ... of the Internet. He also has an idea of where ... right applications to harness increased computing power. , ,Before conducting ... for the National Science Foundation , Landweber spoke at ...
... scale. Source: Imago The Nanostructural Analysis Network ... said it has commissioned an instrument built by Madison-based ... said they were pleased with the installation, which Australian ... Sydney. , ,Imago makes tools to analyse materials down ...
Other Biology Technology:Alumni Association extends database help to university 2Alumni Association extends database help to university 3Landweber on networks, open source, and NSF budget cuts 2Landweber on networks, open source, and NSF budget cuts 3Landweber on networks, open source, and NSF budget cuts 4
(Date:12/4/2009)... with one another for space and dominance. Though the manner ... to be the survival of the fittest, how stem cells ... clear. A study on fruit flies published in the October ... describes how stem cells win this battle by literally sticking ...
(Date:12/4/2009)... is widely used by physicians and scientists to study ... has remained largely unknown whether the electrodes on the ... inside the brain. Scientists at the Max Planck Institute ... a crucial link between the activity generated within the ...
(Date:12/3/2009)... Hausen and his co-workers discovered that specific types of ... out how these pathogens cause cells to degenerate. It ... proteins E6 and E7. Both proteins switch off different ... Professor Dr. Frank Rsl and his co-workers at DKFZ ...
Breaking Biology News(10 mins):Stem cells battle for space 2How to read brain activity? 2Papillomavirus silences innate immune response 2Natural Pepper Skin Sprays Stop Any Itch In Minutes Without Burning 60740 1Natural Pepper Skin Sprays Stop Any Itch In Minutes Without Burning 60740 2Natural Pepper Skin Sprays Stop Any Itch In Minutes Without Burning 60740 3Cell Therapeutics Decreases Net Loss for Nine Month Period in 2009 Compared to Same Period in 2008 by 45 25 60735 1Cell Therapeutics Decreases Net Loss for Nine Month Period in 2009 Compared to Same Period in 2008 by 45 25 60735 2Cell Therapeutics Decreases Net Loss for Nine Month Period in 2009 Compared to Same Period in 2008 by 45 25 60735 3Cell Therapeutics Decreases Net Loss for Nine Month Period in 2009 Compared to Same Period in 2008 by 45 25 60735 4Cell Therapeutics Decreases Net Loss for Nine Month Period in 2009 Compared to Same Period in 2008 by 45 25 60735 5Cell Therapeutics Decreases Net Loss for Nine Month Period in 2009 Compared to Same Period in 2008 by 45 25 60735 6Cell Therapeutics Decreases Net Loss for Nine Month Period in 2009 Compared to Same Period in 2008 by 45 25 60735 7Regences Social Media Web Site Gets a Facelift 60731 1Regences Social Media Web Site Gets a Facelift 60731 2
... University in St. Louis is giving the VIP treatment ... about our biological clock. , VIP is not "very ... originally found in the gut, that is also made ... , Erik Herzog, Ph.D., Washington University assistant professor of ...
... clones of cells from existing human embryonic stem cells. The ... and spinal cord injury. , "This cloning of cells involves ... extracting and then growing a single cell," said UNSW Senior ... is based at the Diabetes Transplant Unit (DTU) at the ...
... aircraft, scientists detected two species of invading plants that ... Kilauea Volcano in the Hawaii Volcanoes National Park. Lead ... of Global Ecology, explained: "We found chemical fingerprints from ... species dominated specific areas. We employed the recently upgraded ...
Other Biology News:Discovery clarifies role of peptide in biological clock 2Stem cell research - new cell lines 2Finding hidden invaders in a Hawaiian rain forest 2Finding hidden invaders in a Hawaiian rain forest 3
... DNA quantitation kit is used to quantitate double-stranded ... of RNA or protein. With this kit, DNA ... be detected with a VersaFluor or other fluorometer. ... 10 ng per ml to 5 micrograms per ...
... MTT, (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrasodium bromide), 50mg/vial. MTT is ... by living cells to yield a dark ... mitochondria, and even freshly dead cells do ... A is a component of Chemicons MTT ...
Piperazine-N',N'-bis(2-ethanesulfonic acid), monosodium salt...
Mouse monoclonal [CAT-2] to Chloramphenicol Acetyltransferase...
Biology Products: